🔎 Trials Near Me

Akèy › Maladi Alzheimer › Kalifòni › San Diego

Etid klinik pou Maladi Alzheimer nan San Diego, CA

12 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Ap rekriteFaz 2
  • Clinical Site, San Diego
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

Predicting Pre-dementia

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Foster Carr MD, San Diego
Laj 55 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07516119

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2
  • UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi lwen
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Ap rekriteFaz 3
  • Local Institution - 2614, San Diego
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Ap rekriteFaz 2
  • Kaizen Brain Center, La Jolla · 11 mi lwen
  • University of California San Diego - La Jolla, La Jolla · 11 mi lwen
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • University of California, San Diego (UCSD) - Medical Center, La Jolla · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Ap rekriteFaz 2/3Volontè an sante akeyi
  • University of California San Diego Medical Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Ap rekriteFaz 2/3Volontè an sante akeyi
  • University of California San Diego Medical Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Ap rekriteFaz 3
  • Artemis Institute for Clinical Research, San Diego
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Ap rekriteFaz 2
  • University of California San Diego, La Jolla · 11 mi lwen
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Ap rekriteFaz 1Volontè an sante akeyi
  • Shiley Marcos Alzheimer's Disease Center, San Diego
Laj 60 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06548191

Alzheimer Prevention Trials (APT) Webstudy

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Https://Www.Aptwebstudy.Org, San Diego
Laj 50 a 85 · Tout sèks · Mizajou Jul 16, 2025 · NCT03638583

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan San Diego

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.